142 related articles for article (PubMed ID: 7497604)
1. Long-term pharmacokinetic behavior of platinum after cisplatin administration.
Gamelin E; Allain P; Maillart P; Turcant A; Delva R; Lortholary A; Larra F
Cancer Chemother Pharmacol; 1995; 37(1-2):97-102. PubMed ID: 7497604
[TBL] [Abstract][Full Text] [Related]
2. Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
Gamelin E; Bouil AL; Boisdron-Celle M; Turcant A; Delva R; Cailleux A; Krikorian A; Brienza S; Cvitkovic E; Robert J; Larra F; Allain P
Clin Cancer Res; 1997 Jun; 3(6):891-9. PubMed ID: 9815764
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.
Dominici C; Petrucci F; Caroli S; Alimonti A; Clerico A; Castello MA
J Clin Oncol; 1989 Jan; 7(1):100-7. PubMed ID: 2909663
[TBL] [Abstract][Full Text] [Related]
4. cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach.
Morazzoni F; Canevali C; Zucchetti M; Caroli S; Alimonti A; Petrucci F; Giudice G; Masoni E; Bedini AV
J Cancer Res Clin Oncol; 1998 Jan; 124(1):37-43. PubMed ID: 9498833
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
[TBL] [Abstract][Full Text] [Related]
6. Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) .
Kim HT; Kim DK; Cho YB; Kim TS; Jung I; Kim KH; Heo DS; Bang YJ; Shin SG; Kim NK
Cancer Chemother Pharmacol; 1998; 41(2):109-16. PubMed ID: 9443623
[TBL] [Abstract][Full Text] [Related]
7. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.
Los G; Blommaert fA; Barton R; Heath DD; den Engelse L; Hanchett C; Vicario D; Weisman R; Robbins KT; Howell SB
Cancer Chemother Pharmacol; 1995; 37(1-2):150-4. PubMed ID: 7497585
[TBL] [Abstract][Full Text] [Related]
8. Platinum pharmacokinetics in sulphur-crested cockatoos (Cacatua galerita) following single-dose cisplatin infusion.
Filippich LJ; Bucher AM; Charles BG
Aust Vet J; 2000 Jun; 78(6):406-11. PubMed ID: 10920780
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
Liu J; Kraut E; Bender J; Brooks R; Balcerzak S; Grever M; Stanley H; D'Ambrosio S; Gibson-D'Ambrosio R; Chan KK
Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.
Sileni VC; Fosser V; Maggian P; Padula E; Beltrame M; Nicolini M; Arslan P
Cancer Chemother Pharmacol; 1992; 30(3):221-5. PubMed ID: 1628371
[TBL] [Abstract][Full Text] [Related]
11. An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia.
Pivot X; Guardiola E; Etienne M; Thyss A; Foa C; Otto J; Schneider M; Magné N; Bensadoun RJ; Renée N; Milano G
Eur J Cancer; 2000 May; 36(7):852-7. PubMed ID: 10785589
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.
Hirai K; Ishiko O; Sumi T; Kanaoka Y; Ogita S
Oncol Rep; 2000; 7(6):1243-5. PubMed ID: 11032923
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic properties of platinium derivatives].
Boisdron-Celle M; Lebouil A; Allain P; Gamelin E
Bull Cancer; 2001 Aug; 88 Spec No():S14-9. PubMed ID: 11567909
[TBL] [Abstract][Full Text] [Related]
15. Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer.
Lagrange JL; Bondiau PY; Tessier E; Chauvel P; Renée N; Etienne MC; Milano G
Int J Cancer; 1996 Nov; 68(4):452-6. PubMed ID: 8945615
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration.
Desoize B; Berthiot G; Manot L; Coninx P; Dumont P
Eur J Cancer; 1996 Sep; 32A(10):1734-8. PubMed ID: 8983282
[TBL] [Abstract][Full Text] [Related]
17. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
18. Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans.
Fournier C; Vennin P; Hecquet B
Cancer Chemother Pharmacol; 1988; 21(1):75-7. PubMed ID: 3342469
[TBL] [Abstract][Full Text] [Related]
19. Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy.
Canaparo R; Casale F; Muntoni E; Zara GP; Della Pepa C; Berno E; Pons N; Fornari G; Eandi M
Br J Clin Pharmacol; 2000 Aug; 50(2):146-53. PubMed ID: 10930966
[TBL] [Abstract][Full Text] [Related]
20. Uptake and retention of platinum in patients undergoing cisplatin therapy.
Jonson R; Börjesson J; Mattsson S; Unsgaard B; Wallgren A
Acta Oncol; 1991; 30(3):315-9. PubMed ID: 2036240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
